{"id":"W2755364308","doi":"10.1200/jco.2017.35.15_suppl.e15723","title":"Efficacy and tolerability of second-line <i>nab</i>-paclitaxel and gemcitabine (NG) after failing first-line FOLFIRINOX in patients (pts) with advanced pancreatic cancer (APC): A single-institution experience.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"FOLFIRINOX; Medicine; Gemcitabine; Irinotecan; Oxaliplatin; Tolerability; Neutropenia; Internal medicine; Regimen; Oncology; Capecitabine; Pancreatic cancer; Progression-free survival; Performance status; Chemotherapy; Chemotherapy regimen; Surgery; Cancer; Adverse effect; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008204178,0.0002219552,0.0004704455,0.0001824513,0.0002464135,0.0006172495,0.0003060767,0.0002874065,0.0009302053],"category_scores_gemma":[0.001375074,0.0001401506,0.0005829875,0.000318207,0.0002232019,0.0003744746,0.0002561102,0.0005956233,0.0002408102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001123124,"about_ca_system_score_gemma":0.000532015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002178532,"about_ca_topic_score_gemma":0.00377202,"domain_scores_codex":[0.9998136,0.00007381878,0.00001959391,0.00003190592,0.00003262912,0.00002846681],"domain_scores_gemma":[0.9993683,0.0001358511,0.0002425198,0.00003216907,0.00004208851,0.0001791909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05031359,0.006852917,0.8103107,0.0003005562,0.0009655856,0.001572501,0.000840596,0.002572465,0.0109332,0.00006108745,0.001472111,0.1138048],"study_design_scores_gemma":[0.005038087,0.1336423,0.8433983,0.00007896937,0.0008622275,0.004824682,0.0005808147,0.003726819,0.005311733,0.00007452323,0.002430144,0.00003141813],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990627,0.0004671332,0.00005004417,0.00003329753,0.000003842973,0.00002731597,0.00007736784,0.000004746751,0.0002735551],"genre_scores_gemma":[0.9991456,0.0002965875,0.0001303762,0.00005867839,0.00001132607,0.0000171622,0.0002077669,0.000002599847,0.0001298165],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002178532,"threshold_uncertainty_score":0.008148909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09823706368127269,"score_gpt":0.4553555421327203,"score_spread":0.3571184784514476,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}